A detailed history of Bailard, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Bailard, Inc. holds 3,059 shares of MCK stock, worth $1.78 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,059
Previous 2,599 17.7%
Holding current value
$1.78 Million
Previous $1.2 Million 36.49%
% of portfolio
0.05%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$473.42 - $539.26 $217,773 - $248,059
460 Added 17.7%
3,059 $1.64 Million
Q4 2023

Feb 02, 2024

BUY
$437.42 - $470.64 $472,851 - $508,761
1,081 Added 71.21%
2,599 $1.2 Million
Q3 2023

Oct 24, 2023

SELL
$402.4 - $446.42 $16,096 - $17,856
-40 Reduced 2.57%
1,518 $660,000
Q2 2023

Jul 20, 2023

SELL
$354.01 - $427.31 $1,770 - $2,136
-5 Reduced 0.32%
1,558 $665,000
Q1 2023

May 08, 2023

BUY
$335.35 - $386.06 $20,456 - $23,549
61 Added 4.06%
1,563 $556,000
Q4 2022

Feb 02, 2023

SELL
$346.68 - $397.58 $20,800 - $23,854
-60 Reduced 3.84%
1,502 $563,000
Q3 2022

Oct 18, 2022

SELL
$321.25 - $373.84 $7,067 - $8,224
-22 Reduced 1.39%
1,562 $531,000
Q2 2022

Jul 27, 2022

BUY
$300.57 - $336.42 $6,612 - $7,401
22 Added 1.41%
1,584 $517,000
Q3 2021

Nov 15, 2021

BUY
$188.42 - $208.66 $76,121 - $84,298
404 Added 34.89%
1,562 $311,000
Q4 2020

Feb 03, 2021

BUY
$143.79 - $183.66 $166,508 - $212,678
1,158 New
1,158 $201,000
Q2 2018

Aug 08, 2018

SELL
$133.4 - $158.13 $190,762 - $226,125
-1,430 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$135.02 - $162.6 $16,877 - $20,325
125 Added 9.58%
1,430 $0
Q2 2017

Aug 11, 2017

BUY
N/A
40 Added 3.16%
1,305 $0
Q3 2016

Jan 29, 2018

SELL
N/A
-72 Reduced 5.39%
1,265 $211,000
Q2 2016

Jan 29, 2018

BUY
N/A
1,337
1,337 $0

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.8B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.